Skip to content
Accessibility help

Search NICE…

Skip to content

Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About

Search results

Skip to results

Area of interest

Area of interestAntimicrobial prescribing (42)COVID-19 (33)

Type

TypeGuidance (3904)Indicators (274)News (248)NICE advice (496)Quality standards (254)Research recommendations (1918)

Status

StatusAwaiting development (338)Discontinued (410)In consultation (5)In development (387)Published (2468)Topic selection (287)

Last updated

Last updatedLast 3 months (74)Last 6 months (137)Last year (579)Last 3 years (1656)

Guidance programme

Guidance programmeAntimicrobial prescribing guidelines (25)Cancer service guidelines (10)Clinical guidelines (381)COVID-19 NHSE/I specialty guides (2)COVID-19 rapid guidelines (27)Diagnostics guidance (93)Health technology evaluations (45)Highly specialised technologies guidance (48)Interventional procedures guidance (953)Medical technologies guidance (152)Medicines practice guidelines (5)NICE guidelines (562)Public health guidelines (88)Safe staffing guidelines (7)Social care guidelines (47)Technology appraisal guidance (2047)

Advice programme

Advice programmeCOVID-19 rapid summaries (8)Evidence summaries (172)Medtech innovation briefings (324)

Showing 6931 to 6945 of 7707 results

Sort by

Rivaroxaban for the prevention of venous thromboembolism in people hospitalised for acute medical conditions [ID463]
Discontinued [GID-TAG427]
Result type
Technology appraisal guidance
Status
Discontinued
Lapatinib in combination with paclitaxel for the first-line treatment of metastatic breast cancer which over-expresses ErbB2 (HER2) receptor [ID517]
Discontinued [GID-TAG436]
Result type
Technology appraisal guidance
Status
Discontinued
Lumacaftor with ivacaftor for treating cystic fibrosis in children aged 2 to 11 years old homozygous for the F508del mutation [ID1486]
Discontinued [GID-TA10390]
Result type
Technology appraisal guidance
Status
Discontinued
Atezolizumab in combination with platinum-based chemotherapy for untreated locally advanced or metastatic urothelial cancer [ID1206]
Discontinued [GID-TA10202]
Result type
Technology appraisal guidance
Status
Discontinued
Galcanezumab for preventing cluster headache [ID1212]
Discontinued [GID-TA10425]
Result type
Technology appraisal guidance
Status
Discontinued
Hepatitis C (genotype 1, chronic) - faldaprevir [ID670]
Discontinued [GID-TAG456]
Result type
Technology appraisal guidance
Status
Discontinued
Lymphoma (follicular non Hodgkin's - advanced) - bortezomib [ID407]
Discontinued [GID-TAG425]
Result type
Technology appraisal guidance
Status
Discontinued
Lusutrombopag for treating thrombocytopenia in people with chronic liver disease needing elective surgery [ID1149]
Discontinued [GID-TA10297]
Result type
Technology appraisal guidance
Status
Discontinued
Atezolizumab for untreated advanced renal cell carcinoma [ID1365]
Discontinued [GID-TA10338]
Result type
Technology appraisal guidance
Status
Discontinued
Arimoclomol for treating Niemann-Pick disease Type C [ID1312]
In development [GID-HST10037] Expected publication date: TBC
Result type
Highly specialised technologies guidance
Status
In development
Lasmiditan for treating acute migraine [ID3759]
Discontinued [GID-TA10807]
Result type
Technology appraisal guidance
Status
Discontinued
Durvalumab with tremelimumab for untreated EGFR- and ALK-negative locally advanced and metastatic non-small-cell lung cancer [ID1538]
Discontinued [GID-TA10422]
Result type
Technology appraisal guidance
Status
Discontinued
Durvalumab for untreated PD-L1-positive metastatic non-small-cell lung cancer [ID3762]
Discontinued [GID-TA10633]
Result type
Technology appraisal guidance
Status
Discontinued
Pembrolizumab with docetaxel for treating hormone-relapsed metastatic prostate cancer untreated with chemotherapy [ID3801]
Discontinued [GID-TA10668]
Result type
Technology appraisal guidance
Status
Discontinued
Avatrombopag for treating chemotherapy-induced thrombocytopenia in non-haematological cancers [ID3837]
Discontinued [GID-TA10737]
Result type
Technology appraisal guidance
Status
Discontinued

Previous page
1
…
461
462
Current page 463
464
465
…
514
Page 463 of 514
Next page

Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Knowledge resources

About NICE
Into practice
Get involved with NICE
Jobs
News
Newsletters and alerts
Contact us
Leave feedback
Reusing our content
NICE UK Open Content Licence
Syndicate our content
Events

Facebook
X
YouTube
LinkedIn

Accessibility
Freedom of information
Glossary
Terms and conditions
Privacy notice
Cookies

© NICE 2024. All rights reserved. Subject to Notice of rights.